EpiCypher

Chapel Hill, United States Founded: 2012 • Age: 14 yrs
Epigenetic kits, reagents, and assays are supplied for research applications.
Request Access

About EpiCypher

EpiCypher is a company based in Chapel Hill (United States) founded in 2012.. EpiCypher has raised $3.43 million across 45 funding rounds from investors including HHS. EpiCypher operates in a competitive market with competitors including Inherent Biosciences, Chronomics, Active Motif, Epiontis and Epigenica, among others.

  • Headquarter Chapel Hill, United States
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Epicypher Inc
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $3.43 M (USD)

    in 45 rounds

  • Latest Funding Round
    $1.27 M (USD), Grant

    Sep 25, 2024

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal
People of EpiCypher
Headcount 10-50
Employee Profiles 28
Board Members and Advisors 4
Employee Profiles
People
Michael-Christopher Keogh
Chief Scientific Officer
People
Sabrina Hunt, Ph.D.
Research Scientist II
People
Zu-Wen Sun
VP, Product Development
People
Marcus Cheek
Director Of Synthetic And Structural Biochemistry (chemistry)

Unlock access to complete

Board Members and Advisors
people
Mark Bedford
Director
people
Or Gozani
Director
people
Brian Strahl
Director
people
Joe McMahon
Director

Unlock access to complete

Funding Insights of EpiCypher

EpiCypher has successfully raised a total of $3.43M across 45 strategic funding rounds. The most recent funding activity was a Grant round of $1.27 million completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 45
  • Last Round Grant — $1.3M
  • First Round

    (02 Apr 2013)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Sep, 2024 Amount Grant - EpiCypher Valuation

investors

HHS
Aug, 2024 Amount Grant - EpiCypher Valuation

investors

HHS
Jun, 2024 Amount Series A - EpiCypher Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in EpiCypher

EpiCypher has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Public health and human services are overseen by HHS.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by EpiCypher

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - EpiCypher

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Epicypher Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of EpiCypher

EpiCypher operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inherent Biosciences, Chronomics, Active Motif, Epiontis and Epigenica, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Epigenetic diagnostics and therapeutics for complex diseases are developed.
domain founded_year HQ Location
Proactive healthcare analysis is enabled by DNA-based epigenetic tests.
domain founded_year HQ Location
Epigenetics and gene regulation research tools are developed and distributed.
domain founded_year HQ Location
Develops epigenetic assays
domain founded_year HQ Location
Provider of solutions for the analysis of genomic data
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Epicypher

Frequently Asked Questions about EpiCypher

When was EpiCypher founded?

EpiCypher was founded in 2012 and raised its 1st funding round 1 year after it was founded.

Where is EpiCypher located?

EpiCypher is headquartered in Chapel Hill, United States. It is registered at Chapel Hill, North Carolina, United States.

Is EpiCypher a funded company?

EpiCypher is a funded company, having raised a total of $3.43M across 45 funding rounds to date. The company's 1st funding round was a Series A of $3.3M, raised on Apr 02, 2013.

What does EpiCypher do?

EpiCypher was founded in 2012 and is based in Chapel Hill, United States. Operations focus on the epigenetics sector, where kits, reagents, and assays are developed for research use. Products offered include antibodies, cell extracts, histone peptide arrays, histone peptides, nucleosomes, peptide synthesis services, and recombinant proteins. Cutana CUTRUN assays are also provided as an alternative to ChIP assays, enabling reduced cell input and broader target profiling.

Who are the top competitors of EpiCypher?

EpiCypher's top competitors include Chronomics, Epigenica and Epiontis.

Who are EpiCypher's investors?

EpiCypher has 1 investor. Key investors include HHS.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available